![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Federal Judge Reiterates Expanded Safe-Harbor Protections for Generics
Federal Judge Reiterates Expanded Safe-Harbor Protections for Generics
August 1, 2013
A federal judge again dismissed Momenta Pharmaceuticals’ patent infringement claims against Teva and Amphastar, reiterating that the Hatch-Waxman Act’s safe-harbor provision extends to generic drugmakers’ use of patented inventions during both pre- and post-approval activities.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
21Oct